Antonio Jimenez Jimenez
@amjimenezmd
Transplantation & Cell Therapy @sylvestercancer • Tweets #MedTwitter #BMTsm #leusm • Opinions and tweets are mine
Why UM/Jackson is an incredible place to train for Hematology-Oncology fellowship: 🌟 NCI-Designated Cancer Center @SylvesterCancer with access to cutting-edge clinical trials and a highly diverse patient population 🩺 Fellows-run continuity clinic at Jackson Memorial where you…
🚨 BIG NEWS in Cell Therapy! 🚨 New donor selection guidelines—developed with @CIBMTR & partners—are now published in the Journal for Transplantation and Cellular Therapy! 🧬 They reflect the latest in GVHD, expanded donor options & search strategies. 🔗 go.nmdp.org/44CTu8N
Donor selection guidelines are out! Grateful to have worked with amazing colleagues and the @CIBMTR and @nmdp_org on this effort. Advances in GVHD prophylaxis support moving beyond strict HLA models toward an integrated approach that brings us closer to a suitable donor for every…
Just Published in @ASTCT_Journal: Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. Read more: sciencedirect.com/science/articl…
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation: brnw.ch/21wTOB1 Authored by: @amjimenezmd, @DrStevenDevine, et al.
Welcome, new interns. May your scrubs stay clean (for at least 30 mins), your consults be brief, and your attendings kind. Hydrate, sleep, ask questions, and never trust a “quick sign-out.” You got this. #July1 #MedTwitter #MedEd
Board-style questions for trainees shouldn’t be locked away. Weekly vignettes focused on TCT, with general heme along the way. 🧠 #BoardPrepWednesday See you every Wednesday. #MedEd #FellowTwitter #HemeTwitter #HOFellows 🔁 @HemOncMiami @HemOncFellows